Drug Profile
DTP-poliovirus vaccine - Daiichi Sankyo/Kitasato Institute/Sanofi
Alternative Names: 4-valent combination DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; DD-687; DTP-IPV - Kitasato Daiichi Sankyo; DTP-IPV vaccine; DTP-poliovirus vaccine (Squarekids); DTP-poliovirus vaccine - Daiichi Sankyo Kitasato Institute/Sanofi; DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; IPV-DTP - Daiichi Sankyo; Petussis, diptheria, tetanus, inactivated-poliovirus Salk vaccine - Kitasato Daiichi Sankyo; Quadrivalent DTP-poliovirus vaccine - Kitasato Daiichi Sankyo; SquarekidsLatest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Kitasato Institute; sanofi pasteur - Daiichi Sankyo Company (JV)
- Developer Daiichi Sankyo Company - Kitasato Institute (JV); Sanofi
- Class Bacterial vaccines; Vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Diphtheria; Pertussis; Poliomyelitis; Tetanus